Summary
Arnaud Amzallag is a Scientific Associate Director in Cambridge, MA with 11 years of experience applying statistical modeling and computational biology to advance drug discovery from early research through clinical stages. At Bristol Myers Squibb he has led multiomics supervised analyses for patient stratification and reverse translation, focusing on solid tumors and mechanisms of drug resistance. His background spans academia and industry—from a PhD at EPFL on DNA biophysics to translational roles at MGH/Harvard, PatientsLikeMe, and biotech consultancies—bringing rigorous statistical learning to biomarker discovery and trial-readout analysis. Known for integrating large genomic datasets with clinical phenodynamics, he bridges domain experts in oncology and immunology to translate insights into actionable biomarker strategies. He maintains an active publication record visible on Google Scholar, reflecting a track record of methodological rigor and translational impact. A less obvious strength is his cross-disciplinary training in bioinformatics, biophysics and communication, which helps him translate complex computational results for clinical and commercial stakeholders.
11 years of coding experience
6 years of employment as a software developer
Weizmann Institute of Science
Master's Degree Bioinformatics, Master's Degree Bioinformatics at ENSIIE - École Nationale Supérieure d'Informatique pour l'Industrie et l'Entreprise
PhD biotechnology biophysics of DNA, PhD biotechnology biophysics of DNA at EPFL
Master's Degree Multimédia and Architecture of Communication, Master's Degree Multimédia and Architecture of Communication at IMAC, Université Panthéon-Assas PARIS II, Paris, France
French, Hebrew, English